Clinical Trial Update: Study to Verify Proper Detection of Supraventricular Tachyarrhythmia With Single-Lead Dual-Chamber Implantable Cardioverter-Defibrillators (ADRIA) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update from Biotronik evaluating whether single-lead, dual-chamber implantable cardioverter-defibrillators properly detect supraventric…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Supraventricular Tachyarrhythmia

Snippet

Sponsor: Biotronik SE & Co. KG | Conditions: Tachyarrhythmia | Phase 4 | Status: COMPLETED